FOXA1 and breast cancer: Together, these data indicate that FOXA1 is able to maintain the BC luminal phenotype also through ER-independent mechanisms and directly repress the basal signature, stimulate apoptosis [36], and prevent the epithelial-to-mesenchymal transition [25,31,41,42].